Eligibility typically requires that you have commercial insurance that doesn't cover the medication (not uninsured entirely), but the rules have evolved and some programs now extend to uninsured patients with qualifying income levels
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Stanisavljevic I, Pavlovic S, Simovic Markovic B, Jurisevic M, Krajnovic T, Mijatovic S, Spasojevic M, Mitrovic S, Corovic I, Jovanovic I
The New England Journal of Medicine, 391 (2), 109121
Since then, GLP-1 RAs have attracted considerable academic interest, leading to the continuous introduction of innovative analogs into the pharmaceutical industry
#GLP1 #HealthcareNews #GLP1Journey #HealthNews #Semaglutide #Tirzepatide | QuickMD- Addiction Treatment, Weight Loss, & Urgent Care via Telemedicine
NICE Technology Appraisal (TA875) recommends semaglutide (Wegovy) only for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds)
